Cargando…

Need vs. Financing Capability: Human Papillomavirus Vaccinations among Adolescents

BACKGROUND: The incidence of Human Papillomavirus (HPV) infection and cervical cancer in adulthood may be prevented by HPV vaccination in adolescence. Currently, the HPV vaccination coverage rate in developing countries is about 15%. The reason for this low vaccination coverage is most likely due to...

Descripción completa

Detalles Bibliográficos
Autores principales: Lismidiati, Wiwin, Emilia, Ova, Widyawati, Widyawati
Formato: Online Artículo Texto
Lenguaje:English
Publicado: West Asia Organization for Cancer Prevention 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982648/
https://www.ncbi.nlm.nih.gov/pubmed/31653141
http://dx.doi.org/10.31557/APJCP.2019.20.10.2959
_version_ 1783491336667660288
author Lismidiati, Wiwin
Emilia, Ova
Widyawati, Widyawati
author_facet Lismidiati, Wiwin
Emilia, Ova
Widyawati, Widyawati
author_sort Lismidiati, Wiwin
collection PubMed
description BACKGROUND: The incidence of Human Papillomavirus (HPV) infection and cervical cancer in adulthood may be prevented by HPV vaccination in adolescence. Currently, the HPV vaccination coverage rate in developing countries is about 15%. The reason for this low vaccination coverage is most likely due to a lack of information among adolescents and adults. PURPOSE: To explore adolescents, parents and teachers’ needs, obstacles, and expectations around the HPV vaccination. METHODS: This research used a qualitative method with a focus group discussion. The research participants were divided into three groups: 21 female students, 17 parents, and 20 teachers. This research was conducted in junior high schools that have programs run by their adolescent reproductive health counseling information centers. The data were analyzed by employing content analysis. RESULTS: HPV vaccination has not been made a priority for adolescents because: 1) There is a lack of available education about HPV and HPV vaccinations for adolescents, parents, and teachers. 2) The high cost for parents to vaccinate their children. 3) Adolescents, parents and teachers believe that the HPV vaccine needs to be administered to adolescents, but they feel that the vaccine is not affordable. CONCLUSION: It is important to consider a program which will provide accurate information about the HPV vaccination to the community, especially adolescents. Financial management, such as insurance or vaccination savings schemes, may be one way to overcome the problem of the HPV vaccination’s cost.
format Online
Article
Text
id pubmed-6982648
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher West Asia Organization for Cancer Prevention
record_format MEDLINE/PubMed
spelling pubmed-69826482020-07-07 Need vs. Financing Capability: Human Papillomavirus Vaccinations among Adolescents Lismidiati, Wiwin Emilia, Ova Widyawati, Widyawati Asian Pac J Cancer Prev Research Article BACKGROUND: The incidence of Human Papillomavirus (HPV) infection and cervical cancer in adulthood may be prevented by HPV vaccination in adolescence. Currently, the HPV vaccination coverage rate in developing countries is about 15%. The reason for this low vaccination coverage is most likely due to a lack of information among adolescents and adults. PURPOSE: To explore adolescents, parents and teachers’ needs, obstacles, and expectations around the HPV vaccination. METHODS: This research used a qualitative method with a focus group discussion. The research participants were divided into three groups: 21 female students, 17 parents, and 20 teachers. This research was conducted in junior high schools that have programs run by their adolescent reproductive health counseling information centers. The data were analyzed by employing content analysis. RESULTS: HPV vaccination has not been made a priority for adolescents because: 1) There is a lack of available education about HPV and HPV vaccinations for adolescents, parents, and teachers. 2) The high cost for parents to vaccinate their children. 3) Adolescents, parents and teachers believe that the HPV vaccine needs to be administered to adolescents, but they feel that the vaccine is not affordable. CONCLUSION: It is important to consider a program which will provide accurate information about the HPV vaccination to the community, especially adolescents. Financial management, such as insurance or vaccination savings schemes, may be one way to overcome the problem of the HPV vaccination’s cost. West Asia Organization for Cancer Prevention 2019 /pmc/articles/PMC6982648/ /pubmed/31653141 http://dx.doi.org/10.31557/APJCP.2019.20.10.2959 Text en This is an Open Access article distributed under the terms of the Creative Commons Attribution License, (http://creativecommons.org/licenses/by/3.0/) which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
Lismidiati, Wiwin
Emilia, Ova
Widyawati, Widyawati
Need vs. Financing Capability: Human Papillomavirus Vaccinations among Adolescents
title Need vs. Financing Capability: Human Papillomavirus Vaccinations among Adolescents
title_full Need vs. Financing Capability: Human Papillomavirus Vaccinations among Adolescents
title_fullStr Need vs. Financing Capability: Human Papillomavirus Vaccinations among Adolescents
title_full_unstemmed Need vs. Financing Capability: Human Papillomavirus Vaccinations among Adolescents
title_short Need vs. Financing Capability: Human Papillomavirus Vaccinations among Adolescents
title_sort need vs. financing capability: human papillomavirus vaccinations among adolescents
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6982648/
https://www.ncbi.nlm.nih.gov/pubmed/31653141
http://dx.doi.org/10.31557/APJCP.2019.20.10.2959
work_keys_str_mv AT lismidiatiwiwin needvsfinancingcapabilityhumanpapillomavirusvaccinationsamongadolescents
AT emiliaova needvsfinancingcapabilityhumanpapillomavirusvaccinationsamongadolescents
AT widyawatiwidyawati needvsfinancingcapabilityhumanpapillomavirusvaccinationsamongadolescents